# iRhythm Acquires VitalConnect for $287.5M to Expand Cardiac Monitoring Platform

> ma · REPORTED · 2026-08-06

iRhythm Holdings entered a definitive agreement to acquire wearable biosensor company VitalConnect for approximately $287.5 million, comprising $237.5 million in cash and $50 million in common stock. The deal adds VitalConnect's FDA-cleared mobile cardiac telemetry, inpatient monitoring, and multi-vitals biosensor capabilities to iRhythm's existing Zio ambulatory cardiac monitoring platform.

About iRhythm: iRhythm is a digital health company that develops wearable cardiac monitoring biosensors and AI-enabled algorithms, primarily serving patients and clinicians who need ambulatory arrhythmia detection.

- Company: iRhythm
- Sector: cardiology
- Primary source: https://investors.irhythmtech.com/news/news-details/2026/iRhythm-to-Acquire-VitalConnect-Expanding-Its-Cardiac-Monitoring-Platform-Across-Ambulatory-Inpatient-and-Hospital-to-Home-Care/default.aspx

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.